// App-Quantinova.ai

: Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy.

Researchers

Presenter

  • David Tomoaki Miyamoto

Principal Investigators

  • Ewan Gibb

  • Kent William Mouw

  • Yang Liu

  • Chin-Lee Wu

  • Michael Drumm

  • Jonathan Lehrer

  • Hussam Al-Deen Ashab

  • Nicholas Erho

  • Marguerite Du Plessis

  • Kaye Ong

  • William U. Shipley

  • Elai Davicioni

  • Jason A. Efstathiou

Medical Centers

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved